国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
19期
2974-2978
,共5页
肖龙%古英明%林秀娟%黄莹%蔡扬%张莹
肖龍%古英明%林秀娟%黃瑩%蔡颺%張瑩
초룡%고영명%림수연%황형%채양%장형
带涤纶环中心静脉导管%血液透析%并发症
帶滌綸環中心靜脈導管%血液透析%併髮癥
대조륜배중심정맥도관%혈액투석%병발증
Dacron cuffed central venous catheter%Hemodialysis%Complication
目的 观察带涤纶环中心静脉留置导管在维持性血液透析患者中作为血管通路的效果及并发症.方法 我科自2005年12月至2012年5月共行带涤纶环中心静脉导管留置术105例次(103例),男55例次(54例),女50例次(49例),年龄17~91岁,平均年龄(59±16.2)岁,均通过颈内静脉留置,术后拍摄胸片确定导管位置.以尿素清除率(URR)和Kt/V作为透析效果的客观评价指标.对照组则包含60例在同一时期使用相同设备,但使用动静脉内瘘进行血透的患者.结果 使用美国Quinton公司生产Permcath带涤纶环双腔导管经颈内静脉入路,99例次经右侧,6例次经左侧,使用1~54个月,平均使用(11.2±10.4)月.常见的并发症有:血流不畅27例169次,发生率4.79例次/1000导管日;感染32例34次,发生率0.96例次/1000导管日.导管组血流量(204±25) ml/min,URR值为(71.3±17.8)%,Kt/V值为(1.34±0.28),与内瘘组比较差异无统计学意义.结论 对于无法行动静脉内瘘和人造血管移植手术的血液透析患者来说,带涤纶环中心静脉留置导管是一种有效的替代方法.
目的 觀察帶滌綸環中心靜脈留置導管在維持性血液透析患者中作為血管通路的效果及併髮癥.方法 我科自2005年12月至2012年5月共行帶滌綸環中心靜脈導管留置術105例次(103例),男55例次(54例),女50例次(49例),年齡17~91歲,平均年齡(59±16.2)歲,均通過頸內靜脈留置,術後拍攝胸片確定導管位置.以尿素清除率(URR)和Kt/V作為透析效果的客觀評價指標.對照組則包含60例在同一時期使用相同設備,但使用動靜脈內瘺進行血透的患者.結果 使用美國Quinton公司生產Permcath帶滌綸環雙腔導管經頸內靜脈入路,99例次經右側,6例次經左側,使用1~54箇月,平均使用(11.2±10.4)月.常見的併髮癥有:血流不暢27例169次,髮生率4.79例次/1000導管日;感染32例34次,髮生率0.96例次/1000導管日.導管組血流量(204±25) ml/min,URR值為(71.3±17.8)%,Kt/V值為(1.34±0.28),與內瘺組比較差異無統計學意義.結論 對于無法行動靜脈內瘺和人造血管移植手術的血液透析患者來說,帶滌綸環中心靜脈留置導管是一種有效的替代方法.
목적 관찰대조륜배중심정맥류치도관재유지성혈액투석환자중작위혈관통로적효과급병발증.방법 아과자2005년12월지2012년5월공행대조륜배중심정맥도관류치술105례차(103례),남55례차(54례),녀50례차(49례),년령17~91세,평균년령(59±16.2)세,균통과경내정맥류치,술후박섭흉편학정도관위치.이뇨소청제솔(URR)화Kt/V작위투석효과적객관평개지표.대조조칙포함60례재동일시기사용상동설비,단사용동정맥내루진행혈투적환자.결과 사용미국Quinton공사생산Permcath대조륜배쌍강도관경경내정맥입로,99례차경우측,6례차경좌측,사용1~54개월,평균사용(11.2±10.4)월.상견적병발증유:혈류불창27례169차,발생솔4.79례차/1000도관일;감염32례34차,발생솔0.96례차/1000도관일.도관조혈류량(204±25) ml/min,URR치위(71.3±17.8)%,Kt/V치위(1.34±0.28),여내루조비교차이무통계학의의.결론 대우무법행동정맥내루화인조혈관이식수술적혈액투석환자래설,대조륜배중심정맥류치도관시일충유효적체대방법.
Objective To investigate the effect and complications of using dacron cuffed central venous catheter as vascular access in the patients undergoing maintenant hemodialysis.Methods 105 cuffed catheters were placed in 103 patients (55 catheters were placed in 54 male patients and 50 catheters in 49 female patients) as vascular access from December,2005 to May,2012.The mean age of these patients was (59.0 ± 16.2) years (range:17~91 years).All catheters were placed via internal jagular vein,and correct catheter placement was determined by X-ray.Urea reduction ratio (URR) and Kt/V were measured to assess the dialysis adequacy.The control group had 60 patients who received dialysis through internal arteriovenous fistulas simultaneously in the same unit.Results 105 catheters (PermCathTM Quinton Instrument) were placed via internal jugular vein (99 right side; 6 left side).Average duration was (11.2 ± 10.4) months (range:1~54 months).Frequent complications were thrombosis or occlusion (169 episodes occurred in 27 patients,at a rate of 4.79 episodes per 1000 catheter days) and infection (34 episodes occurred in 32 patients,at a rate of 0.96 episodes per 1000 catheter days).In the catheter group,the mean value of blood flow,URR,and Kt/V were (204 ± 25) ml/min,(71.3 ± 17.8)% and (1.34 ± 0.28),respectively.There were no significant differences between the catheter group and the control group.Conclusions Dacron cuffed central venous catheter is an effective alternative vascular access especially for patients havig exhausted vascular access sites or patients unable to receive arteriovenous fistula and arteriovenous graft because of congestive heart failure.